CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19

Avicenna J Med Biotechnol. 2022 Jan-Mar;14(1):3-9. doi: 10.18502/ajmb.v14i1.8165.

Abstract

More than a year has passed since the beginning of the 2019 novel coronavirus diseases (COVID-19) pandemic which has created massive problems globally affecting all aspects of people's life. Due to the emergence of new strains of the SARS-CoV-2, pandemic risk still remains, despite the start of vaccination. Therefore, rapid diagnostic tests are essential to control infection, improve clinical care and stop the spread of the disease. Recently CRISPR-based diagnostic tools have facilitated rapid diagnostic. Here, we review the diagnostic applications of CRISPR-Cas system in COVID-19.

Keywords: COVID-19; CRISPR-Cas systems; SARS-CoV-2.

Publication types

  • Review